These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28459537)

  • 1. Comparison of the Deacylase and Deacetylase Activity of Zinc-Dependent HDACs.
    McClure JJ; Inks ES; Zhang C; Peterson YK; Li J; Chundru K; Lee B; Buchanan A; Miao S; Chou CJ
    ACS Chem Biol; 2017 Jun; 12(6):1644-1655. PubMed ID: 28459537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
    Christianson DW
    Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and structural biology of protein lysine deacetylases.
    Yoshida M; Kudo N; Kosono S; Ito A
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(5):297-321. PubMed ID: 28496053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.
    Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ
    Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erasers of histone acetylation: the histone deacetylase enzymes.
    Seto E; Yoshida M
    Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-sirtuin histone deacetylases in the control of cardiac aging.
    Ferguson BS; McKinsey TA
    J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDACs and HDAC Inhibitors in Cancer Development and Therapy.
    Li Y; Seto E
    Cold Spring Harb Perspect Med; 2016 Oct; 6(10):. PubMed ID: 27599530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart.
    Habibian J; Ferguson BS
    Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30597863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.
    Riester D; Wegener D; Hildmann C; Schwienhorst A
    Biochem Biophys Res Commun; 2004 Nov; 324(3):1116-23. PubMed ID: 15485670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Sirtuins: Substrate Specificity and Inhibitor Design.
    Rajabi N; Galleano I; Madsen AS; Olsen CA
    Prog Mol Biol Transl Sci; 2018; 154():25-69. PubMed ID: 29413177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various zinc binding groups on inhibition of histone deacetylases 1-11.
    Madsen AS; Kristensen HM; Lanz G; Olsen CA
    ChemMedChem; 2014 Mar; 9(3):614-26. PubMed ID: 24375963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
    Beyer M; Kiweler N; Mahboobi S; Krämer OH
    Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranslational modifications of histone deacetylases: implications for cardiovascular diseases.
    Eom GH; Kook H
    Pharmacol Ther; 2014 Aug; 143(2):168-80. PubMed ID: 24594235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scaffold dependent histone deacetylase (HDAC) inhibitor induced re-equilibration of the subcellular localization and post-translational modification state of class I HDACs.
    Hanigan TW; Taha TY; Aboukhatwa SM; Frasor J; Petukhov PA
    PLoS One; 2017; 12(10):e0186620. PubMed ID: 29045501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Class 1-Selective Histone Deacetylase (HDAC) Inhibitors Enhance HIV Latency Reversal while Preserving the Activity of HDAC Isoforms Necessary for Maximal HIV Gene Expression.
    Zaikos TD; Painter MM; Sebastian Kettinger NT; Terry VH; Collins KL
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29298886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule inhibitors of zinc-dependent histone deacetylases.
    Wagner FF; Weїwer M; Lewis MC; Holson EB
    Neurotherapeutics; 2013 Oct; 10(4):589-604. PubMed ID: 24101253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylases: salesmen and customers in the post-translational modification market.
    Brandl A; Heinzel T; Krämer OH
    Biol Cell; 2009 Apr; 101(4):193-205. PubMed ID: 19207105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the epigenome: Screening bioactive compounds that regulate histone deacetylase activity.
    Godoy LD; Lucas JE; Bender AJ; Romanick SS; Ferguson BS
    Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27981795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs.
    Schuetze KB; McKinsey TA; Long CS
    J Mol Cell Cardiol; 2014 May; 70():100-7. PubMed ID: 24631770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.